Cargando…
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
Immune reconstitution therapy (IRT) is an emerging management concept for multiple sclerosis, whereby a short course of treatment provides long-lasting suppression of disease activity. “Cladribine tablets 10 mg” refers to a total cumulative dose of cladribine given over 2 years (henceforth referred...
Autores principales: | AlJumah, Mohamed, Alkhawajah, Mona Marwan, Qureshi, Shireen, Al-Thubaiti, Ibtisam, Ayoub, Omar, Bohlega, Saeed A., Bushnag, Areej, Cupler, Edward, Daif, Abdulkader, El Boghdady, Ahmed, Hassan, Ahmed, Al Malik, Yaser, Saeedi, Jameelah, Al-Shamrany, Fawzia, Shosha, Eslam, Rieckmann, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229040/ https://www.ncbi.nlm.nih.gov/pubmed/32056129 http://dx.doi.org/10.1007/s40120-020-00177-5 |
Ejemplares similares
-
Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert Consensus
por: Al Jumah, Mohammed, et al.
Publicado: (2021) -
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a
por: Al Jumah, Mohammed, et al.
Publicado: (2021) -
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
por: Al Jumah, Mohammed, et al.
Publicado: (2021) -
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
por: Alshamrani, Foziah, et al.
Publicado: (2021) -
Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries
por: Aljumah, Mohammed, et al.
Publicado: (2013)